Specific immunotherapy (SIT) in the treatment of allergic rhinitis

SCIENTIFIC BACKGROUND: Allergic rhinitis (AR) exhibits a prevalence of approx. 20% in Germany and causes enormous costs in the health care system. Specific immunotherapy (SIT) is considered to be the only potentially causal therapy for AR and mainly administered by two routes, subcutaneous (SCIT) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagen, Anja, Gorenoi, Vitali, Schönermark, Matthias P.
Formato: Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010882/
https://www.ncbi.nlm.nih.gov/pubmed/21289874
http://dx.doi.org/10.3205/hta000079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010882/
https://www.ncbi.nlm.nih.gov/pubmed/21289874
http://dx.doi.org/10.3205/hta000079

Ejemplares similares